OUR PRODUCTS

MOBILE APPS

GENERAL INFO

SLN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Silence Therapeutics (SLN) Ownership - Who owns Silence Therapeutics?

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

72 Hammersmith Road

Phone

+44 2034576900

Employees

109

Web

https://www.silence-therapeutics.com

Details

Group

Domestic Stock Funds

Fundamentals

SLN

Capitalization

239M

P/E Ratio

N/A

Risk (Beta)

1.80

Dividend Yield

N/A

Total Cash

114M

Total Cash/Share

2.42

Total Debt

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.58%

Revenue

27.2M

ROE

N/A

Book Value

94.2M

P/B Ratio

2.54

Cash Flow

N/A

Earnings

-1.68

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

10.3M

Current Ratio

10.06

Current Revenue Per Employee

1931.03

Dividends Per Share - Security

N/A

EBITDA

-84.82M

Float

N/A

Float - Current

N/A

Gross Income Margin

62.05

Revenue To Assets

-39.19

Shares Held By Institutions

74.7M

Shares Outstanding - Current

47.2M

Total Liabilities

71.1M

Total Volume MTD

N/A

Value

Gain YTD

-26.453

View a ticker or compare two or three

Compare

SLN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For SLN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SLN showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology